SCHEMBL9235404

SCHEMBL9235404

O=C(O)CNC(=O)Oc1ncc(C(=O)NS(=O)(=O)c2ccc(C(=O)NCCc3ccc(F)cc3)cc2)cc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.46
BCL2L1 Q07817 1/20 0.44
MCL1 Q07820 1/20 0.44
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
CA9 Q16790 3/20 0.43
CA12 O43570 2/20 0.43
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TBXA2R P21731 1/20 0.41
TBXAS1 P24557 1/20 0.41
HTT P42858 1/20 0.40
CA7 P43166 1/20 0.40
CA14 Q9ULX7 1/20 0.40
EGFR P00533 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8105999 0.90 MAPT (0.47) MAPTBCL2L1MCL1CA1CA2
SCHEMBL8768266 0.90 ROCK2 (0.46) MAPTBCL2L1MCL1CA1CA2
SCHEMBL8768350 0.87 MAPT (0.44) MAPTBCL2L1MCL1CA1CA2
SCHEMBL8916345 0.86 EGLN1 (0.51) MAPTBCL2L1MCL1CA1CA2
SCHEMBL8768242 0.82 LMNA (0.47) MAPTCA1CA2CA9CA12
SCHEMBL8867801 0.81 MAPT (0.52) MAPTBCL2L1MCL1CA1CA2
SCHEMBL8768423 0.80 LMNA (0.41) PTGS1PTGS2SMN1; SMN2HTTEGFR
SCHEMBL8916374 0.80 ROCK2 (0.48) MAPTBCL2L1MCL1CA1CA2
SCHEMBL8917687 0.78 MAPT (0.45) MAPTBCL2L1MCL1CA1CA2
SCHEMBL7869433 0.78 MAPT (0.50) MAPTBCL2L1MCL1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0673931-A1 Sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1995-09-27 EP disclosed